How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male Participants

Phase 1 Completed 8 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the absorption, metabolism and excretion of \[14C\]-JNT-517 and to characterize and determine the metabolites present in plasma, urine, and feces in healthy male participants following a single oral administration.

Timeline

Start: 2024-01-22
Primary completion: 2025-01-22
Completion: 2025-02-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	JNT-517	Unknown	—	Oral

Indications

No indication recorded.